2015
DOI: 10.1002/dvdy.24247
|View full text |Cite
|
Sign up to set email alerts
|

Heterogeneity in vascular smooth muscle cell embryonic origin in relation to adult structure, physiology, and disease

Abstract: Regional differences in vascular physiology and disease response exist throughout the vascular tree. While these differences in physiology and disease correspond to regional vascular environmental conditions, there is also compelling evidence that the embryonic origins of the smooth muscle inherent to the vessels may play a role. Here we review what is known regarding the role of embryonic origin of vascular smooth muscle cells during vascular development. The focus of this review is to highlight the heterogen… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
28
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 44 publications
(28 citation statements)
references
References 85 publications
0
28
0
Order By: Relevance
“…Somewhat surprisingly, two previously demonstrated stimulators of elastin production by aortic VSMCs, dexamethasone and diazoxide [32,34,36] appeared less active in stimulating elastin biosynthesis in the ascending aortic VSMCs used in the present experiments, compared to that shown previously in cultured VSMCs from the entire aorta [32,34,36]. Here, the relative lack of VSMC responsiveness to these two molecules might be due to the differences in the developmental origin of the ascending aorta, used in the present experiments, and the aortic arch, in which the VSMCs arise from the neural crest, and the remainder of the aorta whose VSMCs arise from the mesoderm [56][57][58][59]. Supporting this hypothesis, aorta from these two different developmental origins have been shown to differentially respond to a variety of other activators.…”
Section: Discussionmentioning
confidence: 88%
“…Somewhat surprisingly, two previously demonstrated stimulators of elastin production by aortic VSMCs, dexamethasone and diazoxide [32,34,36] appeared less active in stimulating elastin biosynthesis in the ascending aortic VSMCs used in the present experiments, compared to that shown previously in cultured VSMCs from the entire aorta [32,34,36]. Here, the relative lack of VSMC responsiveness to these two molecules might be due to the differences in the developmental origin of the ascending aorta, used in the present experiments, and the aortic arch, in which the VSMCs arise from the neural crest, and the remainder of the aorta whose VSMCs arise from the mesoderm [56][57][58][59]. Supporting this hypothesis, aorta from these two different developmental origins have been shown to differentially respond to a variety of other activators.…”
Section: Discussionmentioning
confidence: 88%
“…When a vessel is damaged, a piece of machinery for repair is triggered, and the migration mechanism and proliferation of VSMCs are critical. Accordingly, this entails an increase in the abundance of growth factors (PDGF, TGF, and VEGF) and the volume of the ECM, with the ultimate purpose of reconstructing the vasculature following injury [120,[141][142][143].…”
Section: Hif and Vascular Smooth Muscle Cellsmentioning
confidence: 99%
“…SMC are found in medium, large blood vessels, and arterioles have contractility functions, regulating vascular resistance in the circulatory system, and present elongated, spindle-shaped cells with high concentration of contractile filaments. Besides, they have the ability to modulate their phenotype depending on microenvironment clues, assuming either a differentiated contractile or a synthetic proliferative phenotype [ 264 ]. Surface markers are specific for different SMC; alpha-smooth muscle actin ( α -SMA), for example, is early expressed, while SM22 is higher expressed in differentiated SMC.…”
Section: Cellular Heterogeneity and Blood-organ Barriersmentioning
confidence: 99%